headline large_stringlengths 2 512 | date large_stringlengths 23 23 | article large_stringlengths 29 138k ⌀ | url large_stringlengths 35 1.09k ⌀ | website large_stringclasses 21
values | sentiment_input large_stringlengths 2 19k | company large_stringlengths 2 144 ⌀ | stock_ticker large_stringlengths 1 14 ⌀ | industry large_stringclasses 40
values | industry_etf_ticker large_stringclasses 33
values | economy_keyword large_stringclasses 89
values | economy_ticker large_stringclasses 1
value | date_est large_stringlengths 23 23 | n_companies int32 0 16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B of A Securities Maintains Neutral on Agilent Technologies, Raises Price Target to $88 | 2020-05-22 07:38:59 UTC | null | https://www.benzinga.com/news/20/05/16095304/b-of-a-securities-maintains-neutral-on-agilent-technologies-raises-price-target-to-88 | benzinga.com | B of A Securities Maintains Neutral on Agilent Technologies, Raises Price Target to $88 | agilent | A | null | null | null | 2020-05-22 03:38:59 EDT | 2 | |
B of A Securities Maintains Neutral on Agilent Technologies, Raises Price Target to $88 | 2020-05-22 07:38:59 UTC | null | https://www.benzinga.com/news/20/05/16095304/b-of-a-securities-maintains-neutral-on-agilent-technologies-raises-price-target-to-88 | benzinga.com | B of A Securities Maintains Neutral on Agilent Technologies, Raises Price Target to $88 | target | TGT | null | null | null | 2020-05-22 03:38:59 EDT | 2 | |
CFRA Maintains Hold on Agilent Technologies, Lowers Price Target to $85 | 2020-05-22 07:23:25 UTC | null | https://www.benzinga.com/news/20/05/16095163/cfra-maintains-hold-on-agilent-technologies-lowers-price-target-to-85 | benzinga.com | CFRA Maintains Hold on Agilent Technologies, Lowers Price Target to $85 | agilent | A | null | null | null | 2020-05-22 03:23:25 EDT | 2 | |
CFRA Maintains Hold on Agilent Technologies, Lowers Price Target to $85 | 2020-05-22 07:23:25 UTC | null | https://www.benzinga.com/news/20/05/16095163/cfra-maintains-hold-on-agilent-technologies-lowers-price-target-to-85 | benzinga.com | CFRA Maintains Hold on Agilent Technologies, Lowers Price Target to $85 | target | TGT | null | null | null | 2020-05-22 03:23:25 EDT | 2 | |
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | 2020-05-22 05:36:20 UTC | null | https://www.benzinga.com/news/20/05/16094027/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-87 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | agilent | A | null | null | null | 2020-05-22 01:36:20 EDT | 2 | |
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | 2020-05-22 05:36:20 UTC | null | https://www.benzinga.com/news/20/05/16094027/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-87 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | target | TGT | null | null | null | 2020-05-22 01:36:20 EDT | 2 | |
Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. | 2020-05-22 05:07:04 UTC | null | https://www.benzinga.com/wiim/20/05/16093805/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q2-ep | benzinga.com | Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. | agilent | A | null | null | null | 2020-05-22 01:07:04 EDT | 1 | |
Wells Fargo Maintains Overweight on Agilent Technologies, Raises Price Target to $95 | 2020-05-22 04:37:59 UTC | null | https://www.benzinga.com/news/20/05/16093505/wells-fargo-maintains-overweight-on-agilent-technologies-raises-price-target-to-95 | benzinga.com | Wells Fargo Maintains Overweight on Agilent Technologies, Raises Price Target to $95 | agilent | A | null | null | null | 2020-05-22 00:37:59 EDT | 3 | |
Wells Fargo Maintains Overweight on Agilent Technologies, Raises Price Target to $95 | 2020-05-22 04:37:59 UTC | null | https://www.benzinga.com/news/20/05/16093505/wells-fargo-maintains-overweight-on-agilent-technologies-raises-price-target-to-95 | benzinga.com | Wells Fargo Maintains Overweight on Agilent Technologies, Raises Price Target to $95 | wells fargo | WFC | null | null | null | 2020-05-22 00:37:59 EDT | 3 | |
Wells Fargo Maintains Overweight on Agilent Technologies, Raises Price Target to $95 | 2020-05-22 04:37:59 UTC | null | https://www.benzinga.com/news/20/05/16093505/wells-fargo-maintains-overweight-on-agilent-technologies-raises-price-target-to-95 | benzinga.com | Wells Fargo Maintains Overweight on Agilent Technologies, Raises Price Target to $95 | target | TGT | null | null | null | 2020-05-22 00:37:59 EDT | 3 | |
10 Biggest Price Target Changes For Friday | 2020-05-22 04:06:17 UTC | null | https://www.benzinga.com/analyst-ratings/price-target/20/05/16093262/10-biggest-price-target-changes-for-friday | benzinga.com | 10 Biggest Price Target Changes For Friday | target | TGT | null | null | null | 2020-05-22 00:06:17 EDT | 1 | |
SVB Leerink Maintains Outperform on Agilent Technologies, Raises Price Target to $95 | 2020-05-22 00:00:00 UTC | null | https://www.benzinga.com/news/20/05/16092270/svb-leerink-maintains-outperform-on-agilent-technologies-raises-price-target-to-95 | benzinga.com | SVB Leerink Maintains Outperform on Agilent Technologies, Raises Price Target to $95 | agilent | A | null | null | null | 2020-05-21 20:00:00 EDT | 2 | |
SVB Leerink Maintains Outperform on Agilent Technologies, Raises Price Target to $95 | 2020-05-22 00:00:00 UTC | null | https://www.benzinga.com/news/20/05/16092270/svb-leerink-maintains-outperform-on-agilent-technologies-raises-price-target-to-95 | benzinga.com | SVB Leerink Maintains Outperform on Agilent Technologies, Raises Price Target to $95 | target | TGT | null | null | null | 2020-05-21 20:00:00 EDT | 2 | |
Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. | 2020-05-21 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/05/16089218/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q2-ep | benzinga.com | Agilent Technologies shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. | agilent | A | null | null | null | 2020-05-20 20:00:00 EDT | 1 | |
Agilent Technologies Q2 Adj. EPS $0.71 Beats $0.61 Estimate, Sales $1.24B Beat $1.21B Estimate | 2020-05-21 00:00:00 UTC | null | https://www.benzinga.com/news/earnings/20/05/16088886/agilent-technologies-q2-adj-eps-0-71-beats-0-61-estimate-sales-1-24b-beat-1-21b-estimate | benzinga.com | Agilent Technologies Q2 Adj. EPS $0.71 Beats $0.61 Estimate, Sales $1.24B Beat $1.21B Estimate | agilent | A | null | null | null | 2020-05-20 20:00:00 EDT | 1 | |
Agilent Technologies Receives FDA Approval for PD-L1 as a Companion Diagnostic | 2020-05-18 00:00:00 UTC | null | https://www.benzinga.com/news/20/05/16054223/agilent-technologies-receives-fda-approval-for-pd-l1-as-a-companion-diagnostic | benzinga.com | Agilent Technologies Receives FDA Approval for PD-L1 as a Companion Diagnostic | agilent | A | null | null | null | 2020-05-17 20:00:00 EDT | 1 | |
Pershing Square 13F Shows Fund Raises Stake In Agilent Technologies To 12,626,593 Shares | 2020-05-15 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/20/05/16048806/pershing-square-13f-shows-fund-raises-stake-in-agilent-technologies-to-12-626-593-shares | benzinga.com | Pershing Square 13F Shows Fund Raises Stake In Agilent Technologies To 12,626,593 Shares | square | SQ | null | null | null | 2020-05-14 20:00:00 EDT | 2 | |
Pershing Square 13F Shows Fund Raises Stake In Agilent Technologies To 12,626,593 Shares | 2020-05-15 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/20/05/16048806/pershing-square-13f-shows-fund-raises-stake-in-agilent-technologies-to-12-626-593-shares | benzinga.com | Pershing Square 13F Shows Fund Raises Stake In Agilent Technologies To 12,626,593 Shares | agilent | A | null | null | null | 2020-05-14 20:00:00 EDT | 2 | |
How Bill Ackman Successfully Navigated Coronavirus Market Volatility | 2020-05-08 00:00:00 UTC | null | https://www.benzinga.com/general/education/20/05/15979110/how-bill-ackman-successfully-navigated-coronavirus-market-volatility | benzinga.com | How Bill Ackman Successfully Navigated Coronavirus Market Volatility | null | null | null | null | volatility | 2020-05-07 20:00:00 EDT | 0 | |
Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session. | 2020-05-05 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/05/15957697/shares-of-several-healthcare-companies-are-trading-higher-amid-positive-investor-sentiment-as-some-u | benzinga.com | Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session. | null | null | medical & health care | XLV | null | 2020-05-04 20:00:00 EDT | 0 | |
Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions. | 2020-05-01 00:00:00 UTC | null | https://www.benzinga.com/20/05/15935673/shares-of-several-healthcare-companies-are-trading-lower-as-markets-dip-following-recent-strength-ma | benzinga.com | Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions. | null | null | medical & health care | XLV | null | 2020-04-30 20:00:00 EDT | 0 | |
UBS Maintains Neutral on Agilent Technologies, Lowers Price Target to $84 | 2020-04-28 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15897306/ubs-maintains-neutral-on-agilent-technologies-lowers-price-target-to-84 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Lowers Price Target to $84 | agilent | A | null | null | null | 2020-04-27 20:00:00 EDT | 2 | |
UBS Maintains Neutral on Agilent Technologies, Lowers Price Target to $84 | 2020-04-28 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15897306/ubs-maintains-neutral-on-agilent-technologies-lowers-price-target-to-84 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Lowers Price Target to $84 | target | TGT | null | null | null | 2020-04-27 20:00:00 EDT | 2 | |
Agilent Reports FDA Approval For PD-L1 Companion Diagnostic On Dako Omni | 2020-04-23 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15864339/agilent-reports-fda-approval-for-pd-l1-companion-diagnostic-on-dako-omni | benzinga.com | Agilent Reports FDA Approval For PD-L1 Companion Diagnostic On Dako Omni | agilent | A | null | null | null | 2020-04-22 20:00:00 EDT | 1 | |
Agilent Reports Has Become Top-Level Sponsor Of My Green Lab | 2020-04-22 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15855436/agilent-reports-has-become-top-level-sponsor-of-my-green-lab | benzinga.com | Agilent Reports Has Become Top-Level Sponsor Of My Green Lab | agilent | A | null | null | null | 2020-04-21 20:00:00 EDT | 1 | |
Agilent Withdraws Q2 And FY20 Guidance | 2020-04-14 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15796369/agilent-withdraws-q2-and-fy20-guidance | benzinga.com | Agilent Withdraws Q2 And FY20 Guidance | agilent | A | null | null | null | 2020-04-13 20:00:00 EDT | 1 | |
Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity. | 2020-04-06 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/04/15748126/shares-of-several-healthcare-companies-are-trading-higher-as-markets-gain-amid-optimism-that-coronav | benzinga.com | Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity. | null | null | medical & health care | XLV | null | 2020-04-05 20:00:00 EDT | 0 | |
Stifel Maintains Hold on Agilent Technologies, Lowers Price Target to $73 | 2020-04-02 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15728603/stifel-maintains-hold-on-agilent-technologies-lowers-price-target-to-73 | benzinga.com | Stifel Maintains Hold on Agilent Technologies, Lowers Price Target to $73 | agilent | A | null | null | null | 2020-04-01 20:00:00 EDT | 3 | |
Stifel Maintains Hold on Agilent Technologies, Lowers Price Target to $73 | 2020-04-02 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15728603/stifel-maintains-hold-on-agilent-technologies-lowers-price-target-to-73 | benzinga.com | Stifel Maintains Hold on Agilent Technologies, Lowers Price Target to $73 | target | TGT | null | null | null | 2020-04-01 20:00:00 EDT | 3 | |
Stifel Maintains Hold on Agilent Technologies, Lowers Price Target to $73 | 2020-04-02 00:00:00 UTC | null | https://www.benzinga.com/news/20/04/15728603/stifel-maintains-hold-on-agilent-technologies-lowers-price-target-to-73 | benzinga.com | Stifel Maintains Hold on Agilent Technologies, Lowers Price Target to $73 | stifel | SF | null | null | null | 2020-04-01 20:00:00 EDT | 3 | |
Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities. | 2020-04-01 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/04/15717065/shares-of-several-healthcare-companies-are-trading-lower-amid-market-weakness-as-growing-coronavirus | benzinga.com | Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities. | null | null | medical & health care | XLV | null | 2020-03-31 20:00:00 EDT | 0 | |
Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $82 | 2020-03-30 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15695415/wells-fargo-maintains-overweight-on-agilent-technologies-lowers-price-target-to-82 | benzinga.com | Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $82 | agilent | A | null | null | null | 2020-03-29 20:00:00 EDT | 3 | |
Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $82 | 2020-03-30 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15695415/wells-fargo-maintains-overweight-on-agilent-technologies-lowers-price-target-to-82 | benzinga.com | Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $82 | wells fargo | WFC | null | null | null | 2020-03-29 20:00:00 EDT | 3 | |
Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $82 | 2020-03-30 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15695415/wells-fargo-maintains-overweight-on-agilent-technologies-lowers-price-target-to-82 | benzinga.com | Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $82 | target | TGT | null | null | null | 2020-03-29 20:00:00 EDT | 3 | |
Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak. | 2020-03-27 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/03/15683827/shares-of-several-healthcare-companies-are-trading-lower-selling-off-from-this-weeks-strength-while | benzinga.com | Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak. | null | null | medical & health care | XLV | null | 2020-03-26 20:00:00 EDT | 0 | |
Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors. | 2020-03-26 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/03/15674560/shares-of-several-healthcare-companies-are-trading-higher-following-senate-passage-of-a-2-trillion-e | benzinga.com | Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors. | null | null | medical & health care | XLV | null | 2020-03-25 20:00:00 EDT | 0 | |
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | 2020-03-26 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15673665/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76 | benzinga.com | Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | barclays | BCS | null | null | null | 2020-03-25 20:00:00 EDT | 3 | |
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | 2020-03-26 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15673665/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76 | benzinga.com | Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | agilent | A | null | null | null | 2020-03-25 20:00:00 EDT | 3 | |
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | 2020-03-26 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15673665/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76 | benzinga.com | Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | target | TGT | null | null | null | 2020-03-25 20:00:00 EDT | 3 | |
Citigroup Maintains Neutral on Agilent Technologies, Lowers Price Target to $75 | 2020-03-20 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15615851/citigroup-maintains-neutral-on-agilent-technologies-lowers-price-target-to-75 | benzinga.com | Citigroup Maintains Neutral on Agilent Technologies, Lowers Price Target to $75 | agilent | A | null | null | null | 2020-03-19 20:00:00 EDT | 3 | |
Citigroup Maintains Neutral on Agilent Technologies, Lowers Price Target to $75 | 2020-03-20 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15615851/citigroup-maintains-neutral-on-agilent-technologies-lowers-price-target-to-75 | benzinga.com | Citigroup Maintains Neutral on Agilent Technologies, Lowers Price Target to $75 | citigroup | C | null | null | null | 2020-03-19 20:00:00 EDT | 3 | |
Citigroup Maintains Neutral on Agilent Technologies, Lowers Price Target to $75 | 2020-03-20 00:00:00 UTC | null | https://www.benzinga.com/news/20/03/15615851/citigroup-maintains-neutral-on-agilent-technologies-lowers-price-target-to-75 | benzinga.com | Citigroup Maintains Neutral on Agilent Technologies, Lowers Price Target to $75 | target | TGT | null | null | null | 2020-03-19 20:00:00 EDT | 3 | |
Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy. | 2020-03-16 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/03/15558425/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-on-cont | benzinga.com | Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy. | null | null | medical & health care | XLV | null | 2020-03-15 20:00:00 EDT | 0 | |
Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears. | 2020-03-02 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/03/15456786/shares-of-several-healthcare-companies-are-trading-higher-in-sympathy-with-the-overall-market-as-it | benzinga.com | Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears. | null | null | medical & health care | XLV | null | 2020-03-01 19:00:00 EST | 0 | |
Needham Downgrades Agilent Technologies to Hold, Announces $85 Price Target | 2020-02-24 00:00:00 UTC | null | https://www.benzinga.com/news/20/02/15391251/needham-downgrades-agilent-technologies-to-hold-announces-85-price-target | benzinga.com | Needham Downgrades Agilent Technologies to Hold, Announces $85 Price Target | agilent | A | null | null | null | 2020-02-23 19:00:00 EST | 2 | |
Needham Downgrades Agilent Technologies to Hold, Announces $85 Price Target | 2020-02-24 00:00:00 UTC | null | https://www.benzinga.com/news/20/02/15391251/needham-downgrades-agilent-technologies-to-hold-announces-85-price-target | benzinga.com | Needham Downgrades Agilent Technologies to Hold, Announces $85 Price Target | target | TGT | null | null | null | 2020-02-23 19:00:00 EST | 2 | |
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $90 | 2020-02-19 00:00:00 UTC | null | https://www.benzinga.com/news/20/02/15363071/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-90 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $90 | agilent | A | null | null | null | 2020-02-18 19:00:00 EST | 2 | |
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $90 | 2020-02-19 00:00:00 UTC | null | https://www.benzinga.com/news/20/02/15363071/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-90 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $90 | target | TGT | null | null | null | 2020-02-18 19:00:00 EST | 2 | |
Agilent Technologies shares are trading lower after the company reported Q1 earnings. | 2020-02-18 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/02/15358745/agilent-technologies-shares-are-trading-lower-after-the-company-reported-q1-earnings | benzinga.com | Agilent Technologies shares are trading lower after the company reported Q1 earnings. | agilent | A | null | null | null | 2020-02-17 19:00:00 EST | 1 | |
Agilent Reaffirms FY20 Guidance: Adj. EPS $3.38-$3.43 vs $3.42 Estimate, Sales $5.5B-$5.55B vs $5.54B Est. | 2020-02-18 00:00:00 UTC | null | https://www.benzinga.com/news/20/02/15358631/agilent-reaffirms-fy20-guidance-adj-eps-3-38-3-43-vs-3-42-estimate-sales-5-5b-5-55b-vs-5-54b-est | benzinga.com | Agilent Reaffirms FY20 Guidance: Adj. EPS $3.38-$3.43 vs $3.42 Estimate, Sales $5.5B-$5.55B vs $5.54B Est. | agilent | A | null | null | null | 2020-02-17 19:00:00 EST | 1 | |
Agilent Technologies Q1 EPS $0.81, Inline, Sales $1.36B Up From $1.284B YoY | 2020-02-18 00:00:00 UTC | null | https://www.benzinga.com/news/earnings/20/02/15358612/agilent-technologies-q1-eps-0-81-inline-sales-1-36b-up-from-1-284b-yoy | benzinga.com | Agilent Technologies Q1 EPS $0.81, Inline, Sales $1.36B Up From $1.284B YoY | agilent | A | null | null | null | 2020-02-17 19:00:00 EST | 1 | |
Pershing Square 13F Shows Raised Stake In Agilent By 11.4% To 3.25M Shares | 2020-02-14 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/20/02/15343262/pershing-square-13f-shows-raised-stake-in-agilent-by-11-4-to-3-25m-shares | benzinga.com | Pershing Square 13F Shows Raised Stake In Agilent By 11.4% To 3.25M Shares | square | SQ | null | null | null | 2020-02-13 19:00:00 EST | 2 | |
Pershing Square 13F Shows Raised Stake In Agilent By 11.4% To 3.25M Shares | 2020-02-14 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/20/02/15343262/pershing-square-13f-shows-raised-stake-in-agilent-by-11-4-to-3-25m-shares | benzinga.com | Pershing Square 13F Shows Raised Stake In Agilent By 11.4% To 3.25M Shares | agilent | A | null | null | null | 2020-02-13 19:00:00 EST | 2 | |
Twist Bioscience Reports Settlement Deal With Agilent; Co. Will Pay Agilent $22.5M | 2020-02-06 00:00:00 UTC | null | https://www.benzinga.com/news/20/02/15274626/twist-bioscience-reports-settlement-deal-with-agilent-co-will-pay-agilent-22-5m | benzinga.com | Twist Bioscience Reports Settlement Deal With Agilent; Co. Will Pay Agilent $22.5M | agilent | A | null | null | null | 2020-02-05 19:00:00 EST | 2 | |
Twist Bioscience Reports Settlement Deal With Agilent; Co. Will Pay Agilent $22.5M | 2020-02-06 00:00:00 UTC | null | https://www.benzinga.com/news/20/02/15274626/twist-bioscience-reports-settlement-deal-with-agilent-co-will-pay-agilent-22-5m | benzinga.com | Twist Bioscience Reports Settlement Deal With Agilent; Co. Will Pay Agilent $22.5M | twist bioscience | TWST | null | null | null | 2020-02-05 19:00:00 EST | 2 | |
Pershing Square Sees 'Substantial Opportunity' For Improvement In Agilent's A.N Business Performance | 2020-02-05 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/20/02/15261019/pershing-square-sees-substantial-opportunity-for-improvement-in-agilents-a-n-business-perform | benzinga.com | Pershing Square Sees 'Substantial Opportunity' For Improvement In Agilent's A.N Business Performance | square | SQ | null | null | null | 2020-02-04 19:00:00 EST | 2 | |
Pershing Square Sees 'Substantial Opportunity' For Improvement In Agilent's A.N Business Performance | 2020-02-05 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/20/02/15261019/pershing-square-sees-substantial-opportunity-for-improvement-in-agilents-a-n-business-perform | benzinga.com | Pershing Square Sees 'Substantial Opportunity' For Improvement In Agilent's A.N Business Performance | agilent | A | null | null | null | 2020-02-04 19:00:00 EST | 2 | |
Agilent shares are trading lower. Not seeing any news to justify the price action. | 2020-01-30 00:00:00 UTC | null | https://www.benzinga.com/wiim/20/01/15218404/agilent-shares-are-trading-lower-not-seeing-any-news-to-justify-the-price-action | benzinga.com | Agilent shares are trading lower. Not seeing any news to justify the price action. | agilent | A | null | null | null | 2020-01-29 19:00:00 EST | 1 | |
Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $100 Price Target | 2020-01-08 00:00:00 UTC | null | https://www.benzinga.com/news/20/01/15090063/wells-fargo-initiates-coverage-on-agilent-technologies-with-overweight-rating-announces-100-price-ta | benzinga.com | Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $100 Price Target | agilent | A | null | null | null | 2020-01-07 19:00:00 EST | 3 | |
Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $100 Price Target | 2020-01-08 00:00:00 UTC | null | https://www.benzinga.com/news/20/01/15090063/wells-fargo-initiates-coverage-on-agilent-technologies-with-overweight-rating-announces-100-price-ta | benzinga.com | Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $100 Price Target | wells fargo | WFC | null | null | null | 2020-01-07 19:00:00 EST | 3 | |
Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $100 Price Target | 2020-01-08 00:00:00 UTC | null | https://www.benzinga.com/news/20/01/15090063/wells-fargo-initiates-coverage-on-agilent-technologies-with-overweight-rating-announces-100-price-ta | benzinga.com | Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $100 Price Target | target | TGT | null | null | null | 2020-01-07 19:00:00 EST | 3 | |
Citigroup Initiates Coverage On Agilent Technologies with Neutral Rating, Announces $85 Price Target | 2020-01-07 00:00:00 UTC | null | https://www.benzinga.com/news/20/01/15082753/citigroup-initiates-coverage-on-agilent-technologies-with-neutral-rating-announces-85-price-target | benzinga.com | Citigroup Initiates Coverage On Agilent Technologies with Neutral Rating, Announces $85 Price Target | agilent | A | null | null | null | 2020-01-06 19:00:00 EST | 3 | |
Citigroup Initiates Coverage On Agilent Technologies with Neutral Rating, Announces $85 Price Target | 2020-01-07 00:00:00 UTC | null | https://www.benzinga.com/news/20/01/15082753/citigroup-initiates-coverage-on-agilent-technologies-with-neutral-rating-announces-85-price-target | benzinga.com | Citigroup Initiates Coverage On Agilent Technologies with Neutral Rating, Announces $85 Price Target | citigroup | C | null | null | null | 2020-01-06 19:00:00 EST | 3 | |
Citigroup Initiates Coverage On Agilent Technologies with Neutral Rating, Announces $85 Price Target | 2020-01-07 00:00:00 UTC | null | https://www.benzinga.com/news/20/01/15082753/citigroup-initiates-coverage-on-agilent-technologies-with-neutral-rating-announces-85-price-target | benzinga.com | Citigroup Initiates Coverage On Agilent Technologies with Neutral Rating, Announces $85 Price Target | target | TGT | null | null | null | 2020-01-06 19:00:00 EST | 3 | |
41 Healthcare Stocks Moving In Tuesday's Pre-Market Session | 2019-12-10 00:00:00 UTC | null | https://www.benzinga.com/news/19/12/14961880/41-healthcare-stocks-moving-in-tuesdays-pre-market-session | benzinga.com | 41 Healthcare Stocks Moving In Tuesday's Pre-Market Session | null | null | medical & health care | XLV | null | 2019-12-09 19:00:00 EST | 0 | |
UPDATE: Bill Ackman's Pershing Square Files Amended 13F Showing New ~2.916M Share Stake In Agilent | 2019-12-09 00:00:00 UTC | null | https://www.benzinga.com/news/19/12/14957797/update-bill-ackmans-pershing-square-files-amended-13f-showing-new-2-916m-share-stake-in-agilent | benzinga.com | UPDATE: Bill Ackman's Pershing Square Files Amended 13F Showing New ~2.916M Share Stake In Agilent | square | SQ | null | null | null | 2019-12-08 19:00:00 EST | 2 | |
UPDATE: Bill Ackman's Pershing Square Files Amended 13F Showing New ~2.916M Share Stake In Agilent | 2019-12-09 00:00:00 UTC | null | https://www.benzinga.com/news/19/12/14957797/update-bill-ackmans-pershing-square-files-amended-13f-showing-new-2-916m-share-stake-in-agilent | benzinga.com | UPDATE: Bill Ackman's Pershing Square Files Amended 13F Showing New ~2.916M Share Stake In Agilent | agilent | A | null | null | null | 2019-12-08 19:00:00 EST | 2 | |
Hearing Pershing Square Reports 2.9M Share Stake In Agilent | 2019-12-09 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/19/12/14957729/hearing-pershing-square-reports-2-9m-share-stake-in-agilent | benzinga.com | Hearing Pershing Square Reports 2.9M Share Stake In Agilent | square | SQ | null | null | null | 2019-12-08 19:00:00 EST | 2 | |
Hearing Pershing Square Reports 2.9M Share Stake In Agilent | 2019-12-09 00:00:00 UTC | null | https://www.benzinga.com/general/hedge-funds/19/12/14957729/hearing-pershing-square-reports-2-9m-share-stake-in-agilent | benzinga.com | Hearing Pershing Square Reports 2.9M Share Stake In Agilent | agilent | A | null | null | null | 2019-12-08 19:00:00 EST | 2 | |
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | 2019-11-26 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14883967/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-87 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | agilent | A | null | null | null | 2019-11-25 19:00:00 EST | 2 | |
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | 2019-11-26 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14883967/ubs-maintains-neutral-on-agilent-technologies-raises-price-target-to-87 | benzinga.com | UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $87 | target | TGT | null | null | null | 2019-11-25 19:00:00 EST | 2 | |
Agilent Sees FY20 Adj. EPS $3.38-$3.43 vs $3.44 Estimate, Sales $5.5B-$5.55B vs $5.55B Est. | 2019-11-25 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14880011/agilent-sees-fy20-adj-eps-3-38-3-43-vs-3-44-estimate-sales-5-5b-5-55b-vs-5-55b-est | benzinga.com | Agilent Sees FY20 Adj. EPS $3.38-$3.43 vs $3.44 Estimate, Sales $5.5B-$5.55B vs $5.55B Est. | agilent | A | null | null | null | 2019-11-24 19:00:00 EST | 1 | |
Agilent Sees Q1 Adj. EPS $0.80-$0.81 vs $0.84 Estimate, Sales $1.34B-$1.355B vs $1.38B Est. | 2019-11-25 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14880008/agilent-sees-q1-adj-eps-0-80-0-81-vs-0-84-estimate-sales-1-34b-1-355b-vs-1-38b-est | benzinga.com | Agilent Sees Q1 Adj. EPS $0.80-$0.81 vs $0.84 Estimate, Sales $1.34B-$1.355B vs $1.38B Est. | agilent | A | null | null | null | 2019-11-24 19:00:00 EST | 1 | |
Agilent Technologies Q4 Adj. EPS $0.89 Beats $0.85 Estimate, Sales $1.37B Beat $1.33B Estimate | 2019-11-25 00:00:00 UTC | null | https://www.benzinga.com/news/earnings/19/11/14880002/agilent-technologies-q4-adj-eps-0-89-beats-0-85-estimate-sales-1-37b-beat-1-33b-estimate | benzinga.com | Agilent Technologies Q4 Adj. EPS $0.89 Beats $0.85 Estimate, Sales $1.37B Beat $1.33B Estimate | agilent | A | null | null | null | 2019-11-24 19:00:00 EST | 1 | |
Agilent Raises Qtr. Dividend From $0.164 To $0.18/Share | 2019-11-20 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14852619/agilent-raises-qtr-dividend-from-0-164-to-0-18share | benzinga.com | Agilent Raises Qtr. Dividend From $0.164 To $0.18/Share | agilent | A | null | null | null | 2019-11-19 19:00:00 EST | 1 | |
Stifel Nicolaus Initiates Coverage On Agilent Technologies with Hold Rating, Announces $85 Price Target | 2019-11-15 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14818776/stifel-nicolaus-initiates-coverage-on-agilent-technologies-with-hold-rating-announces-85-price-targe | benzinga.com | Stifel Nicolaus Initiates Coverage On Agilent Technologies with Hold Rating, Announces $85 Price Target | agilent | A | null | null | null | 2019-11-14 19:00:00 EST | 3 | |
Stifel Nicolaus Initiates Coverage On Agilent Technologies with Hold Rating, Announces $85 Price Target | 2019-11-15 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14818776/stifel-nicolaus-initiates-coverage-on-agilent-technologies-with-hold-rating-announces-85-price-targe | benzinga.com | Stifel Nicolaus Initiates Coverage On Agilent Technologies with Hold Rating, Announces $85 Price Target | target | TGT | null | null | null | 2019-11-14 19:00:00 EST | 3 | |
Stifel Nicolaus Initiates Coverage On Agilent Technologies with Hold Rating, Announces $85 Price Target | 2019-11-15 00:00:00 UTC | null | https://www.benzinga.com/news/19/11/14818776/stifel-nicolaus-initiates-coverage-on-agilent-technologies-with-hold-rating-announces-85-price-targe | benzinga.com | Stifel Nicolaus Initiates Coverage On Agilent Technologies with Hold Rating, Announces $85 Price Target | stifel | SF | null | null | null | 2019-11-14 19:00:00 EST | 3 | |
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Fed Speakers | 2019-10-18 00:00:00 UTC | null | https://www.benzinga.com/news/earnings/19/10/14618733/a-peek-into-the-markets-us-stock-futures-edge-higher-ahead-of-fed-speakers | benzinga.com | A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Fed Speakers | null | null | null | null | fed | 2019-10-17 20:00:00 EDT | 0 | |
UBS Downgrades Agilent Technologies to Neutral, Announces $82 Price Target | 2019-10-18 00:00:00 UTC | null | https://www.benzinga.com/news/19/10/14618513/ubs-downgrades-agilent-technologies-to-neutral-announces-82-price-target | benzinga.com | UBS Downgrades Agilent Technologies to Neutral, Announces $82 Price Target | agilent | A | null | null | null | 2019-10-17 20:00:00 EDT | 2 | |
UBS Downgrades Agilent Technologies to Neutral, Announces $82 Price Target | 2019-10-18 00:00:00 UTC | null | https://www.benzinga.com/news/19/10/14618513/ubs-downgrades-agilent-technologies-to-neutral-announces-82-price-target | benzinga.com | UBS Downgrades Agilent Technologies to Neutral, Announces $82 Price Target | target | TGT | null | null | null | 2019-10-17 20:00:00 EDT | 2 | |
Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today. | 2019-10-11 00:00:00 UTC | null | https://www.benzinga.com/markets/wiim/19/10/14582266/shares-of-several-healthcare-companies-are-trading-higher-after-president-trump-made-positive-remark | benzinga.com | Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today. | premier | PINC | medical & health care | XLV | null | 2019-10-10 20:00:00 EDT | 1 | |
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | 2019-10-09 00:00:00 UTC | null | https://www.benzinga.com/news/19/10/14566662/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76 | benzinga.com | Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | barclays | BCS | null | null | null | 2019-10-08 20:00:00 EDT | 3 | |
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | 2019-10-09 00:00:00 UTC | null | https://www.benzinga.com/news/19/10/14566662/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76 | benzinga.com | Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | agilent | A | null | null | null | 2019-10-08 20:00:00 EDT | 3 | |
Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | 2019-10-09 00:00:00 UTC | null | https://www.benzinga.com/news/19/10/14566662/barclays-maintains-equal-weight-on-agilent-technologies-lowers-price-target-to-76 | benzinga.com | Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $76 | target | TGT | null | null | null | 2019-10-08 20:00:00 EDT | 3 | |
Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15. | 2019-10-08 00:00:00 UTC | null | https://www.benzinga.com/markets/wiim/19/10/14561148/shares-of-several-healthcare-companies-are-trading-lower-with-the-broader-market-after-the-us-expand | benzinga.com | Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15. | null | null | technology | XLK | null | 2019-10-07 20:00:00 EDT | 0 | |
Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15. | 2019-10-08 00:00:00 UTC | null | https://www.benzinga.com/markets/wiim/19/10/14561148/shares-of-several-healthcare-companies-are-trading-lower-with-the-broader-market-after-the-us-expand | benzinga.com | Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15. | null | null | medical & health care | XLV | null | 2019-10-07 20:00:00 EDT | 0 | |
Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week. | 2019-10-02 00:00:00 UTC | null | https://www.benzinga.com/markets/wiim/19/10/14530664/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-on-cont | benzinga.com | Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week. | null | null | medical & health care | XLV | recession | 2019-10-01 20:00:00 EDT | 0 | |
Shares of several healthcare companies are trading higher in sympathy with the overall market after the Chinese Minister of Commerce said the leaders of the U.S. and China are set to meet in Washington D.C in early October. Investors hope the meeting could bring the two countries closer to a trade deal. | 2019-09-05 00:00:00 UTC | null | https://www.benzinga.com/markets/wiim/19/09/14385950/shares-of-several-healthcare-companies-are-trading-higher-in-sympathy-with-the-overall-market-after | benzinga.com | Shares of several healthcare companies are trading higher in sympathy with the overall market after the Chinese Minister of Commerce said the leaders of the U.S. and China are set to meet in Washington D.C in early October. Investors hope the meeting could bring the two countries closer to a trade deal. | null | null | medical & health care | XLV | null | 2019-09-04 20:00:00 EDT | 0 | |
Agilent Collaborates On Study Of Performance-Enhancing Spinach Extract | 2019-09-03 00:00:00 UTC | null | https://www.benzinga.com/general/19/09/14364782/agilent-collaborates-on-study-of-performance-enhancing-spinach-extract | benzinga.com | Agilent Collaborates On Study Of Performance-Enhancing Spinach Extract | agilent | A | null | null | null | 2019-09-02 20:00:00 EDT | 1 | |
Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates. | 2019-08-15 00:00:00 UTC | null | https://www.benzinga.com/markets/wiim/19/08/14275943/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-ep | benzinga.com | Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates. | agilent | A | null | null | null | 2019-08-14 20:00:00 EDT | 1 | |
Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates. | 2019-08-14 00:00:00 UTC | null | https://www.benzinga.com/markets/wiim/19/08/14270855/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-ep | benzinga.com | Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates. | agilent | A | null | null | null | 2019-08-13 20:00:00 EDT | 1 | |
Agilent Technologies Sees Q4 Adj. EPS $0.84-$0.86 vs $0.87 Est., Sales $1.31B-$1.33B vs $1.34B Est., Sees FY19 Adj. EPS $3.07-$3.08 vs $3.05 Est., Sales $5.105B-$5.125B vs $5.11B Est. | 2019-08-14 00:00:00 UTC | null | https://www.benzinga.com/news/19/08/14270614/agilent-technologies-sees-q4-adj-eps-0-84-0-86-vs-0-87-est-sales-1-31b-1-33b-vs-1-34b-est-sees-fy19 | benzinga.com | Agilent Technologies Sees Q4 Adj. EPS $0.84-$0.86 vs $0.87 Est., Sales $1.31B-$1.33B vs $1.34B Est., Sees FY19 Adj. EPS $3.07-$3.08 vs $3.05 Est., Sales $5.105B-$5.125B vs $5.11B Est. | agilent | A | null | null | null | 2019-08-13 20:00:00 EDT | 1 | |
Agilent Technologies Q3 Adj. EPS $0.76 Beats $0.72 Estimate, Sales $1.27B Beat $1.24B Estimate | 2019-08-14 00:00:00 UTC | null | https://www.benzinga.com/news/earnings/19/08/14270569/agilent-technologies-q3-adj-eps-0-76-beats-0-72-estimate-sales-1-27b-beat-1-24b-estimate | benzinga.com | Agilent Technologies Q3 Adj. EPS $0.76 Beats $0.72 Estimate, Sales $1.27B Beat $1.24B Estimate | agilent | A | null | null | null | 2019-08-13 20:00:00 EDT | 1 | |
Q3 Earnings Preview For Agilent Technologies | 2019-08-14 00:00:00 UTC | null | https://www.benzinga.com/news/earnings-previews/19/08/14262424/earnings-preview-agilent-technologies | benzinga.com | Q3 Earnings Preview For Agilent Technologies | agilent | A | null | null | null | 2019-08-13 20:00:00 EDT | 1 | |
Agilent Shares Unaffected As Hearing FDA Approved Co.'s PD-L1 IHC 22C3 PharmDx Assay For Expanded Use | 2019-07-31 00:00:00 UTC | null | https://www.benzinga.com/news/19/07/14172596/agilent-shares-unaffected-as-hearing-fda-approved-co-s-pd-l1-ihc-22c3-pharmdx-assay-for-expanded-use | benzinga.com | Agilent Shares Unaffected As Hearing FDA Approved Co.'s PD-L1 IHC 22C3 PharmDx Assay For Expanded Use | agilent | A | null | null | null | 2019-07-30 20:00:00 EDT | 1 | |
Bank of America Downgrades Agilent Technologies to Neutral | 2019-07-16 00:00:00 UTC | null | https://www.benzinga.com/news/19/07/14079253/bank-of-america-downgrades-agilent-technologies-to-neutral | benzinga.com | Bank of America Downgrades Agilent Technologies to Neutral | agilent | A | null | null | null | 2019-07-15 20:00:00 EDT | 2 | |
Bank of America Downgrades Agilent Technologies to Neutral | 2019-07-16 00:00:00 UTC | null | https://www.benzinga.com/news/19/07/14079253/bank-of-america-downgrades-agilent-technologies-to-neutral | benzinga.com | Bank of America Downgrades Agilent Technologies to Neutral | bank of america | BAC | null | null | null | 2019-07-15 20:00:00 EDT | 2 | |
Barclays Downgrades Agilent Technologies to Equal-Weight, Lowers Price Target to $78 | 2019-07-15 00:00:00 UTC | null | https://www.benzinga.com/news/19/07/14071989/barclays-downgrades-agilent-technologies-to-equal-weight-lowers-price-target-to-78 | benzinga.com | Barclays Downgrades Agilent Technologies to Equal-Weight, Lowers Price Target to $78 | barclays | BCS | null | null | null | 2019-07-14 20:00:00 EDT | 3 | |
Barclays Downgrades Agilent Technologies to Equal-Weight, Lowers Price Target to $78 | 2019-07-15 00:00:00 UTC | null | https://www.benzinga.com/news/19/07/14071989/barclays-downgrades-agilent-technologies-to-equal-weight-lowers-price-target-to-78 | benzinga.com | Barclays Downgrades Agilent Technologies to Equal-Weight, Lowers Price Target to $78 | agilent | A | null | null | null | 2019-07-14 20:00:00 EDT | 3 |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 49